P16 Expression in Squamous Cell Carcinomas of Cervix and Bladder

@article{CioffiLavina2010P16EI,
  title={P16 Expression in Squamous Cell Carcinomas of Cervix and Bladder},
  author={Maureen Cioffi-Lavina and Jennifer Rose Chapman-Fredricks and Carmen R. Gomez-Fernandez and Parvin Ganjei‐Azar and Murigesan Manoharan and Merc{\'e} Jord{\'a}},
  journal={Applied Immunohistochemistry \& Molecular Morphology},
  year={2010},
  volume={18},
  pages={344-347}
}
Context/Objectivep16 is a widely used immunohistochemical marker in gynecologic pathology. Strong and diffuse cytoplasmic and nuclear expression of p16 in squamous cell carcinomas (SCC) of the female genital tract is strongly associated with high-risk human papilloma virus infection and neoplasms of cervical origin. However, p16 can be expressed in other neoplasms and in several normal human tissues. Occasionally, SCCs may involve both uterine cervix and urinary bladder. Accurate identification… 

IMMUNOHISTOCHEMICAL EXPRESSION OF P16 IN CERVICAL AND URINARY BLADDER SQUAMOUS CELL CARCINOMA

Background: p16 is a tumor suppressor protein important in regulating cell cycle. In bladder cancer, p16 mutations are widespread and tend to be more prevalent in low-grade superficial tumors than in

Expression of P 16 Tumor Marker in Cervical Cancer among Sudanese Women

Immunohistochemical evaluation of p16 shows p16 expression was strongly observed in cervical cancer but has no correlation with type and grade of cervical cancer.

Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection

This is the first report of squamous tumors arising in the setting of concurrent neurogenic bladder and HPV infection, similar to that of other high-risk HPV-associated squamous carcinomas with a basaloid, poorly differentiated appearance and little to no keratin formation.

Ki-67 and P16 proteins in cervical cancer and precancerous lesions of young women and the diagnostic value for cervical cancer and precancerous lesions

The combined detection of Ki-67 and P16 protein has a high application prospect as an auxiliary diagnosis of SCC and is positively correlated with the degree of cervical lesions.

P16INK4A Immunohistochemistry as a Gold Standard for Cervical Cancer and Precursor Lesions Screening

The molecular biomarker p16INK4a can be a good candidate for the early diagnosis and prognosis of cervical cancer in HPV-infected patients because of the increase in the expression level of p16ink4a in cancer and precancer tissues.

Papillary urothelial carcinoma with squamous differentiation in association with human papilloma virus: case report and literature review.

This study case demonstrates HPV infection with a low risk subtype (HPV 6/11) associated with an urothelial carcinoma with squamous differentiation and condylomatous features.

Pathological possibilities and pitfalls in detecting aggressive bladder cancer

Molecular-based detection techniques represent potentially attractive strategies for noninvasive detection of aggressive bladder cancer using urine as the specimen source, but are currently limited by their sensitivity and potential for false-positive results, and are unlikely to substitute cystoscopy.

Uterine myxoid leiomyosarcoma – a rare malignant tumor: the role of complex morphopathological assay. Review and case presentation

A case where MLMS was postoperatively confirmed with the aid of the histopathological (HP) examination coupled with specific immunolabeling techniques, and the following microscopic characteristics laid the foundation for the diagnosis.

Urinary Bladder and Urachus

This chapter addresses biopsies from the urinary bladder by profiling immunohistochemical stains that change their patterns of expression from that of normal urothelium, including both the cellular layers and cellular compartments in which markers are expressed.

References

SHOWING 1-10 OF 14 REFERENCES

p16 Expression in the Female Genital Tract and Its Value in Diagnosis

In cervical squamous lesions, p16 is positive in most high-grade cervical intraepithelial neoplasia (CIN) and in some cases of low-grade CIN, usually those associated with high-risk HPV, whereas the more common non-HPV-associated neoplasms are largely negative or focally positive.

Immunohistochemical Expression of p16(INK4A) in Normal Uterine Cervix, Nonneoplastic Epithelial Lesions, and Low-grade Squamous Intraepithelial Lesions

Objectives. In this study, the authors analyzed the immunoexpression of p16 in high-risk human papillomavirus DNA-negative normal and nonneoplastic cervical epithelia, in low-grade cervical

Expression of p16, Rb, and p53 Proteins in Squamous Cell Carcinomas of the Anorectal Region Harboring Human Papillomavirus DNA

Observations indicate that overexpression of p16 and loss of Rb nuclear staining are commonly associated with high-risk HPV infection, which may serve as useful surrogate biomarkers for identifying squamous cell carcinomas harboring HPV DNA.

Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia.

The utility of p16(Ink4a) in discriminating between cervical intraepithelial neoplasia 1 and nonneoplastic equivocal lesions of the cervix.

The data support the routine use of p16(Ink4a) immunohistochemical evaluation of cervical biopsy specimens for better discrimination of non-HPV-associated lesions from HPV-related lesions.

Squamous Cell Carcinoma of the Bladder: A Clinicopathologic Analysis of 45 Cases

In conclusion, squamous cell carcinoma often presents at an advanced stage; however, radical cystectomy with lymph node dissection appears to offer a significant benefit in survival in a subset of patients.

p16INK4a Immunohistochemistry Improves Interobserver Agreement in the Diagnosis of Cervical Intraepithelial Neoplasia

It has been repeatedly shown that there is a substantial lack of interobserver reproducibility in the histologic diagnosis of cervical intraepithelial neoplasia (CIN), which might be improved by a

p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.